Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

NCT07363044 is registered in ClinicalTrials.gov with Alimentiv Inc. as lead sponsor.

NCT NCT07363044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07363044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Lead sponsor
Alimentiv Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2025
Completion date
January 31, 2029
Enrollment
378 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease (cd)